Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery
Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.
In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.
Download whitepaper
Global market expansion and the future of precision medicine: The case for internationalization
As the precision medicine market continues to grow at pace and organizations across R&D, healthcare, and academia pivot to a personalized approach – delivering the right treatment to the right patient at the right time – the case for international collaboration and global expansion has never been stronger.
This whitepaper explores global market trends, the ways precision medicine is improving patient outcomes while reducing costs and increasing return on investment, and how unified data policies and breakthrough technologies are driving the rapid expansion of the international market.
What's inside:
- Defining precision medicine: Why it matters, and how it can deliver improved patient outcomes while reducing costs and increasing ROI
- Expansion into international markets: From North America’s current dominance, to booming markets in Asia Pacific and South America
- Challenges of implementation: Addressing vast data volumes, high clinical trial failure rates, emerging ethical concerns, and a shortage of genetics and big data specialists
- A strategic future for precision medicine: How policy development and breakthrough technologies are driving collaboration and global market expansion
Download to learn more.